PCUK Nurse Jeni Posted January 25, 2013 Posted January 25, 2013 Hi,At the recent ASCO (American Society of Clinical Oncology) conference, announcements were made about the drug ABRAXANE (Nab-Paclitaxel) and its use in metastatic pancreatic cancer. Results of clinical trials showed some promising benefit from the drug, when combined with gemcitabine.You can read more about this here:http://www.pancreaticcancer.org.uk/about-us/media-centre/press-releases-and-comments/cancer-drug-extends-survival-in-patients-with-advanced-pancreatic-cancer-by-nearly-two-monthsWe look forward to hearing more about this, and in particular, its licencing for use in the UK.Support Team.
Recommended Posts